1    INTRODUCTION   

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology 
    2.1 Research Methodology 
    2.2 Secondary and Primary Research Methodology 
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology 
    2.4 Market Forecast Methodology 
    2.5 Market Data Validation and Triangulation 
    2.6 Assumptions for the Study

3 Executive Summary 
    3.1 Introduction 
    3.2 Conclusion

4 Premium Insights 
    4.1 High-Performance Liquid Chromatography (HPLC): Market Overview 
    4.2 Geographic Analysis: HPLC Market, By Application (2016) 
    4.3 Global HPLC Market Share, By Product, 2016 vs 2021 
    4.4 Geographical Snapshot of the HPLC Market

5 Market Overview 
    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                    5.2.1.1 High Sensitivity and Accuracy of HPLC
                    5.2.1.2 Growing Popularity of the LC-MS Technique
                    5.2.1.3 Growing Importance of HPLC Tests in Drug Approvals
                    5.2.1.4 Increasing Life Science R&D Spending
           5.2.2 Restraint
                    5.2.2.1 High Cost of Equipment
           5.2.3 Opportunities
                    5.2.3.1 Increasing Use of Chromatography in the Purification of Monoclonal Antibodies
                    5.2.3.2 Emerging Markets in India and China
                    5.2.3.3 Emergence of Biobanking
           5.2.4 Challenge
                    5.2.4.1 Extensive Requirements for Developing Systems That Generate Pressures Above 20,000 PSI

6 High-Performance Liquid Chromatography Market, By Product 
    6.1 Introduction 
    6.2 Instruments 
           6.2.1 Systems
           6.2.2 Detectors
           6.2.3 Pumps
           6.2.4 Fraction Collectors
    6.3 Consumables 
           6.3.1 Columns
                    6.3.1.1 Reverse-Phase HPLC Columns
                    6.3.1.2 Normal-Phase/Hydrophilic Interaction HPLC Columns
                    6.3.1.3 Ion Exchange HPLC Columns
                    6.3.1.4 Other Columns
           6.3.2 Filters
           6.3.3 Vials
           6.3.4 Tubes
    6.4 Accessories

7 High-Performance Liquid Chromatography Market, By Application 
    7.1 Introduction 
    7.2 Clinical Research 
    7.3 Diagnostics 
    7.4 Forensics 
    7.5 Other Applications

8 High-Performance Liquid Chromatography Market, By Region 
    8.1 Introduction 
    8.2 North America 
           8.2.1 U.S.
                    8.2.1.1 Increasing Funding for R&D
                    8.2.1.2 Preclinical Activities By Cros and Pharmaceutical Companies
                    8.2.1.3 U.S.-China Collaborative Program for Biomedical Research
           8.2.2 Canada
                    8.2.2.1 Government Initiatives to Improve Laboratory Infrastructure
                    8.2.2.2 Growth in the Food Testing Industry in Ontario
                    8.2.2.3 Growing Intensity of Pharmaceutical and Biopharmaceutical Clinical Research
    8.3 Europe 
           8.3.1 Germany
                    8.3.1.1 Flourishing Biotechnology and Life Sciences Industry
           8.3.2 U.K.
                    8.3.2.1 Increased Investments in Pharmaceutical Development
           8.3.3 Rest of Europe (RoE)
                    8.3.3.1 Focus of the Pharmaceutical Market Players to Enhance Their Presence in France
                    8.3.3.2 Funding From Local and Government Agencies in Spain
                    8.3.3.3 Russia’s Booming Pharmaceutical Industry
    8.4 Asia-Pacific (APAC) 
           8.4.1 Japan
                    8.4.1.1 Growth in Biomedical and Medical Research in Japan
           8.4.2 China
                    8.4.2.1 Strategic Expansions By Key Players in China
                    8.4.2.2 Outsourcing of Clinical Research Activities to China
           8.4.3 India
                    8.4.3.1 Increasing Government Initiatives and Growing Pharmaceutical Industry in India
           8.4.4 Rest of Asia-Pacific (RoAPAC)
                    8.4.4.1 Favorable Regulatory Scenario in New Zealand and Australia
    8.5 Rest of the World (RoW) 
           8.5.1 Latin America
                    8.5.1.1 Growth in the Biotechnology & Pharmaceutical Industries in Brazil
           8.5.2 Middle East and Africa (MEA)
                    8.5.2.1 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE
                    8.5.2.2 Increasing Focus of Pharmaceutical Companies in Africa

9 Competitive Landscape 
    9.1 Overview 
    9.2 Market Share Analysis 
           9.2.1 Introduction
           9.2.2 Waters Corporation
           9.2.3 Agilent Technologies, Inc.
           9.2.4 Shimadzu Corporation
    9.3 Empirical Assessment of Growth Strategies 
    9.4 Competitive Situation and Trends 
           9.4.1 Product Launches
           9.4.2 Expansions
           9.4.3 Agreements, Collaborations, and Partnerships
           9.4.4 Acquisitions
           9.4.5 Other Strategies

10 Company Profiles
     10.1 Introduction 
     10.2 Waters Corporation 
     10.3 Agilent Technologies, Inc. 
     10.4 Shimadzu Corporation 
     10.5 Thermo Fisher Scientific Inc. 
     10.6 GE Healthcare 
     10.7 Perkinelmer, Inc. 
     10.8 Bio-Rad Laboratories, Inc. 
     10.9 Gilson, Inc. 
     10.10 Phenomenex, Inc. 
     10.11 Jasco, Inc.